To test for a similar effect in vivo, we checked whether topical application of pro-ferroptosis inhibitors of Gpx4 or the cystine-glutamate antiporter system xc– would produce a psoriasis-like phenotype in mice. The gene discussed is GPX4; the disease is psoriasis.